Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
DXCM - DexCom, Inc.
Market Cap 47.99B P/E 171.96 EPS this Y 15.80% Ern Qtrly Grth 179.20%
Income 541.5M Forward P/E 77.38 EPS next Y 27.30% 50D Avg Chg -2.00%
Sales 3.62B PEG 2.28 EPS past 5Y 31.86% 200D Avg Chg 6.00%
Dividend N/A Price/Book 22.76 EPS next 5Y 33.40% 52W High Chg -11.00%
Recommedations 1.60 Quick Ratio 2.39 Shares Outstanding 396.03M 52W Low Chg 57.00%
Insider Own 0.36% ROA 6.41% Shares Float 379.87M Beta 1.21
Inst Own 100.77% ROE 25.78% Shares Shorted/Prior 11.77M/15.87M Price 123.81
Gross Margin 63.19% Profit Margin 14.95% Avg. Volume 2,692,864 Target Price 151.32
Oper. Margin 20.97% Earnings Date Apr 25 Volume 3,172,027 Change 1.48%
Healthcare | Medical Devices | United States
About DexCom, Inc.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

DexCom, Inc. News
04/24/24 Wall Street Bulls Look Optimistic About DexCom (DXCM): Should You Buy?
04/23/24 DexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
04/23/24 Boston Scientific, Dexcom and Edwards next as earnings season rolls on
04/22/24 Ahead of DexCom (DXCM) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
04/22/24 Zacks Investment Ideas feature highlights: Vertiv, Align Technology and DexCom
04/22/24 DexCom Insiders Sold US$18m Of Shares Suggesting Hesitancy
04/19/24 Even IBD 50 Medical Products Stocks Don't All Look Healthy In This Sick Market
04/19/24 Dexcom In Buy Zone After Launch Of Prescription-Free Diabetes Monitor; Earnings Due Next Week
04/19/24 3 Innovative Stocks to Buy Before Earnings Amid the Market Pullback
04/18/24 Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
04/16/24 EVP Strategy and Corporate Dev Matthew Dolan Sells Shares of DexCom Inc (DXCM)
04/16/24 Zacks Industry Outlook Highlights Edwards Lifesciences, DexCom and STERIS
04/16/24 14 Best 52-Week High Stocks To Invest In Now
04/15/24 DexCom (DXCM) Stock Moves -1.16%: What You Should Know
04/15/24 3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
04/15/24 DexCom (DXCM), MD Revolution Unite to Boost Diabetes Management
04/12/24 Why Wall Street Got Even More Excited About The Glucose Monitor — And How Dexcom, Abbott Labs Stand To Benefit
04/11/24 Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?
04/10/24 Insider Sell: DexCom Inc (DXCM) President, CEO and Chairman Kevin Sayer Sells 49,633 Shares
04/10/24 Nasdaq Nightmares: 3 Stocks to Sell Before Reality Sets In
DXCM Chatroom

User Image trondisc Posted - 22 minutes ago

4/23 UBER passenger of mine injected insulin pen into right side of stomach. He wanted $MNKD Afrezza but didn’t want to chance having to inhale a 2nd follow up dose. Guy wished Technosphere had $DXCM like data monitoring (beyond titration)/digital integration; awesome music to my ears. Asked him, “Afrezza has been hostage from Tier 3/4 insurance coverage, does this factor into your decision versus if it were in the common tier 1/2?” Answer: “It doesn’t really matter, I’ll pay a little more out of pocket.” -guy from Los Gatos. Meanwhile, Cramer 4/24/24 says Liquitradetheftdia is a “dice roll.” #UnderstatementOfTheYear #Castagnant #MathIsNotHard #ChiefExcuseOfficer #Paltry29kProfit #ReadySetInhale #Access4Patients #MediocreMike #NewLeadershipNow #BotchedUAE #TechnosphereSquandered #MoronMike #RetirementUnfux0red #TrueLongs #MidTierMike #PreReverseSplit #MalignantMike #MalaiseMike #MisguidedMike #GiveHimTheGuillotine #MinorLeagueMike #MismanagementMike #PfefferSucks #Hooper4CEO

User Image AdamCrush Posted - 17 hours ago

$DXCM ceo at Northwestern saying GLP1 pose significant long term risk to biz. Why would that be?

User Image ShortingTheTrend Posted - 20 hours ago

$DXCM anyone got Flow info from BLBX?

User Image JFDI Posted - 21 hours ago

$DXCM looking better and better.

User Image ShortingTheTrend Posted - 1 day ago

$DXCM bull flag on the 5min

User Image ShortingTheTrend Posted - 1 day ago

$DXCM inside bar on the daily, MACD curling is upwards, looks like a green doji candle for yesterday suggesting green ahead.

User Image ShortingTheTrend Posted - 2 days ago

$DXCM I think earnings will push higher

User Image Godel_Logic Posted - 3 days ago

$DXCM Does anyone know when Stelo, the first FDA-cleared glucose biosensor available without a prescription will be available on the market?

User Image Clargy Posted - 6 days ago

$DXCM Earnings will determine if this LT breakout is validated.

User Image JFDI Posted - 6 days ago

$DXCM

User Image Iwillplay Posted - 1 week ago

$DXCM F you losers! Trump '24!

User Image ShortingTheTrend Posted - 1 week ago

$DXCM I was right, triple bottom 🐂🐂🐂

User Image ShortingTheTrend Posted - 1 week ago

$DXCM triple bottom? 🐂🐃🐃

User Image ShortingTheTrend Posted - 1 week ago

$DXCM 131.74 = double top... Until we drop there I'll remain 🐂

User Image long_knw Posted - 1 week ago

$KNW But $DXCM has this problem solved and a non-invasive solution won’t immediately have millions of customers lining up. Right…

User Image ShortingTheTrend Posted - 1 week ago

$DXCM if you have shares you can use this Long Butterfly strategy as long as it stays above $110 https://www.investors.com/research/options/dexcom-stock-option-trade-could-return-465-while-risking-just-35/

User Image ShortingTheTrend Posted - 1 week ago

$DXCM double top... Same exact pattern it had last month is playing out now... Maybe back to 140 on Tues/Wed next week?

User Image lcdoslcdos Posted - 1 week ago

@crheat I have been $DXCM holder since 2016, I wonder what this means to them. Maybe their moat is in chemistry and patent. If so I guess supplier improvement is a plus, not negative because of proliferation.

User Image Dr_Stoxx Posted - 1 week ago

$DXCM: from @InvestorsBusinessDaily Leaderboard, building a 2nd order base on the hourly chart. Breakout over 141. Found using @MarketSurge.

User Image Dr_Stoxx Posted - 1 week ago

$APO $DXCM $NVO $DDOG DDOG above 130 today. NVO over 125. DXCM flat. APO down a bit.

User Image AnchorsAweigh Posted - 1 week ago

$DXCM really like this one

User Image insiderbuyingselling Posted - 2 weeks ago

$DXCM new insider selling: 49633 shares. http://insiderbuyingselling.com/?t=DXCM

User Image Dr_Stoxx Posted - 2 weeks ago

$APO $DXCM $NVO $DDOG

User Image Stocktwits Posted - 2 weeks ago

$APO $DXCM $NVO $DDOG Stocks to watch 👀

User Image Dr_Stoxx Posted - 2 weeks ago

Note what is green today. Relative strength is a big key to profitable trading. $APO $DDOG $DXCM $NVO

User Image AnchorsAweigh Posted - 2 weeks ago

$TTD $DXCM RS

User Image ShortingTheTrend Posted - 2 weeks ago

$DXCM switched trendline around cus that bearish continuation wedge isn't playing out.... Either a bull flag or bullish rectangle... And earnings 24th

User Image tradeoption Posted - 2 weeks ago

$DXCM Will fly tomorrow.

User Image ShortingTheTrend Posted - 2 weeks ago

$DXCM UBS raises target from $153 to $163

User Image Johnny_Lever Posted - 2 weeks ago

$DXCM Reclaiming that ATH again today and closing above support.

Analyst Ratings
UBS Buy Apr 10, 24
Citigroup Buy Apr 3, 24
RBC Capital Outperform Mar 12, 24
Raymond James Strong Buy Jan 23, 24
Raymond James Strong Buy Jan 3, 24
Piper Sandler Overweight Dec 19, 23
Wells Fargo Overweight Dec 13, 23
Morgan Stanley Equal-Weight Dec 4, 23
Morgan Stanley Equal-Weight Oct 27, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Stern Sadie EVP Chief Human Reso.. EVP Chief Human Resources Jan 12 Sell 123.63 2,902 358,774 79,051 01/17/24
Sylvain Jereme M EVP Chief Financial.. EVP Chief Financial Officer Jan 12 Sell 123.63 2,734 338,004 74,505 01/17/24
SAYER KEVIN R President, CEO and C.. President, CEO and Chairman Jan 12 Sell 123.63 37,325 4,614,490 362,841 01/17/24
Leach Jacob Steven EVP Chief Operating.. EVP Chief Operating Officer Jan 12 Sell 123.63 3,978 491,800 262,499 01/17/24
ALTMAN STEVEN R Director Director Jan 16 Sell 122.6 1,568 192,237 53,132 01/17/24
Stern Sadie EVP Chief Human Reso.. EVP Chief Human Resources Offi Dec 11 Sell 117.66 392 46,123 76,008 12/11/23
Brown Michael Jon EVP Chief Legal Offi.. EVP Chief Legal Officer Dec 01 Sell 114.5 3,612 413,574 58,394 12/04/23
Naganathan Girish EVP Chief Technology.. EVP Chief Technology Officer Nov 09 Sell 93.27 2,725 254,161 47,725 11/27/23
Stern Sadie EVP Chief Human Reso.. EVP Chief Human Resources Offi Nov 22 Sell 110.0 1,176 129,360 76,400 11/24/23
ALTMAN STEVEN R Director Director Nov 15 Sell 101.256 1,000 101,256 59,700 11/15/23
Regan Barry J. EVP Operations EVP Operations Nov 08 Sell 95.22 2,019 192,249 64,250 11/08/23
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Oct 23 Sell 85.75 411 35,243 125,186 10/23/23
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Sep 22 Sell 88.4 411 36,332 125,597 09/22/23
Heller Bridgette P Director Director Sep 12 Sell 106.56 600 63,936 23,731 09/13/23
Dolan Matthew Vincent SVP Corporate Strate.. SVP Corporate Strategy-Develop Sep 01 Sell 102.32 56 5,730 33,569 09/01/23
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Aug 23 Sell 107.03 411 43,989 126,008 08/23/23
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Jul 24 Sell 130.58 412 53,799 126,419 07/24/23
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Jul 14 Sell 136.0 5,031 684,216 126,831 07/17/23
Stern Sadie EVP Chief Human Reso.. EVP Chief Human Resources Offi Jul 10 Sell 128.05 392 50,196 82,074 07/10/23
Regan Barry J. EVP Operations EVP Operations Jul 10 Sell 128.05 1,989 254,691 66,269 07/10/23
Selvaraj Shelly Ramasamy SVP Chief Informatio.. SVP Chief Information Officer Jun 15 Sell 130.0014 2,115 274,953 50,390 06/15/23
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V May 23 Sell 118.65 412 48,884 132,274 05/23/23
Sylvain Jereme M EVP Chief Financial.. EVP Chief Financial Officer May 22 Sell 117.58 2,400 282,192 74,711 05/23/23
Stern Sadie EVP Chief Human Reso.. EVP Chief Human Resources Offi May 09 Sell 120.19 393 47,235 82,859 05/09/23
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Apr 27 Sell 126.0 5,031 633,906 132,686 04/27/23
Leach Jacob Steven EVP Chief Technology.. EVP Chief Technology Officer Apr 20 Sell 125.0 30,764 3,845,500 259,613 04/20/23
Regan Barry J. EVP Operations EVP Operations Apr 20 Sell 124.5 2,214 275,643 68,258 04/20/23
Selvaraj Shelly Ramasamy SVP Chief Informatio.. SVP Chief Information Officer Apr 20 Sell 125.0 2,007 250,875 52,505 04/20/23
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Mar 23 Sell 116.4 5,442 633,449 138,129 03/27/23
Leach Jacob Steven EVP Chief Technology.. EVP Chief Technology Officer Mar 06 Sell 114.79 18,144 2,082,750 281,089 03/06/23
Dolan Matthew Vincent SVP Corporate Strate.. SVP Corporate Strategy-Develop Mar 06 Sell 114.4 226 25,854 26,536 03/06/23
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Feb 23 Sell 111.64 412 45,996 136,464 02/23/23
Regan Barry J. EVP Operations EVP Operations Jan 30 Sell 106.12 2,213 234,844 59,386 01/31/23
SAYER KEVIN R President CEO and Ch.. President CEO and Chairman of Jan 30 Sell 106.35 56,844 6,045,359 369,801 01/31/23
Flynn Paul R EVP Global Revenue EVP Global Revenue Dec 08 Sell 123.5 8,988 1,110,018 55,744 12/08/22
Dolan Matthew Vincent SVP Corporate Strate.. SVP Corporate Strategy-Develop Sep 01 Sell 81.63 5 408 26,536 09/06/22
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Aug 23 Sell 84.21 1,000 84,210 137,700 08/24/22
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Jul 25 Sell 83.07 1,000 83,070 138,700 07/25/22
Pacelli Steven Robert EVP Managing Directo.. EVP Managing Director Dexcom V Jun 23 Sell 72.55 1,000 72,550 139,700 06/27/22
Patterson Chad EVP Global Marketing EVP Global Marketing May 09 Sell 342.77 777 266,332 13,675 05/10/22
Pacelli Steven Robert Managing Dir., Dexco.. Managing Dir., Dexcom Ventures Apr 25 Sell 439.94 250 109,985 35,425 04/27/22
Patterson Chad EVP, Global Marketin.. EVP, Global Marketing Apr 11 Sell 498.75 776 387,030 14,452 04/13/22
Regan Barry J. EVP Global Operation.. EVP Global Operations Mar 29 Sell 500.0 1,106 553,000 16,345 03/30/22
Pacelli Steven Robert Managing Dir., Dexco.. Managing Dir., Dexcom Ventures Mar 23 Sell 459.98 250 114,995 35,675 03/24/22
Patterson Chad EVP, Global Marketin.. EVP, Global Marketing Mar 10 Sell 401.27 776 311,386 15,228 03/14/22
Selvaraj Shelly Ramasamy SVP Chief Informatio.. SVP Chief Information Officer Mar 10 Sell 401.27 2,366 949,405 11,454 03/14/22
Sylvain Jereme M EVP, Chief Financial.. EVP, Chief Financial Officer Mar 04 Sell 422.94 600 253,764 14,662 03/04/22
Pacelli Steven Robert Managing Dir., Dexco.. Managing Dir., Dexcom Ventures Feb 23 Sell 394.33 250 98,582 34,370 02/24/22
SAYER KEVIN R Chairman, CEO & Pres.. Chairman, CEO & President Feb 14 Sell 418.04 3,000 1,254,120 94,617 02/15/22
KAHN BARBARA Director Director Feb 10 Sell 442.28 4,666 2,063,678 3,000 02/14/22